Evidence map›Paper›PMID 28338012›Full record

ArticleScientific reports2017

Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying bla

Liang Xia, Yang Liu, Shu Xia, Timothy Kudinha, Shu-Nian Xiao, Nan-Shan Zhong, Guo-Sheng Ren, Chao Zhuo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. CTX-M-producingOne health (Amsterdam, Netherlands) · 2023
    Article
  8. Antimicrobial Resistance and Clonal Lineages ofAntibiotics (Basel, Switzerland) · 2023
    Review
  9. F18:A-:B1 Plasmids CarryingAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Prevalence and molecular characteristics of polymyxin-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  13. Article
  14. Article
  15. Rapid ResaCeftazidime-AvibactamJournal of clinical microbiology · 2022
    Article
  16. Prevalence ofTropical medicine and infectious disease · 2022
    Article
  17. Review
  18. Article
  19. Prevalence of Chromosomally LocatedMicrobiology spectrum · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Liang XiaState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Yang LiuState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Shu XiaState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Timothy KudinhaCharles Sturt University, Leeds Parade, Orange, New South Wales, Australia.
Shu-Nian XiaoState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Nan-Shan ZhongState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Guo-Sheng RenThe First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Chao ZhuoState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
First Affiliated Hospital of Guangzhou Medical University · CNState Key Laboratory of Respiratory Disease · CNCharles Sturt University · AUChongqing Medical University · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study molecular epidemiology of CTX-M-55-carrying Escherichia coli isolates from urinary tract infections (UTIs) in China. 111 bla

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial Agentsbeta-LactamasesChildChild, PreschoolChinaEscherichia coliEscherichia coli InfectionsFemaleHumansInfantMaleMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID28338012
PMCPMC5364490
OpenAlexW2597720691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.